Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
Launched by NORTHWELL HEALTH · Jun 8, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effectiveness of an electrical muscle stimulation (EMS) device for treating patellofemoral pain syndrome, which is a common cause of pain in the front of the knee, often referred to as anterior knee pain. The goal is to see if using EMS alongside regular physical therapy (PT) can help patients recover faster and improve their overall outcomes compared to those who only receive PT. In this study, half of the participants will use the EMS device in addition to PT, while the other half will only receive PT.
To be eligible for this trial, participants must be between 18 and 40 years old and have had knee pain for more than three months. They should also experience pain when sitting with their knees bent, going downstairs, kneeling, squatting, or during sports activities. Participants will be closely monitored throughout the study to evaluate their progress. It's important to note that individuals with certain knee injuries, previous surgeries, or specific medical conditions, such as pregnancy, may not be eligible to participate. If you or someone you know is struggling with knee pain and meets the eligibility criteria, this trial could be a potential opportunity to explore new treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bilateral/unilateral anterior knee pain for more than 3 moths
- • Age of patient 18 to 40 years
- • At least 3 of the 4 following criteria present: pain associated with prolonged sitting with knees bend, pain with going downstairs, kneeling and squatting or sports activities
- • No h/o injury
- • No h/o surgery to the knee
- Exclusion Criteria:
- • H/o patellar dislocation or subluxation
- • Associated bursitis, tendinitis in periarticular area
- • Ligamentous problems
- • Intra-articular pathology
- • Pregnancy (patient reported pregnancy, in case of doubt patient will be referred to their OBG/GYN physician to exclude the pregnancy)
- • H/o knee surgery
- • Oral or intraarticular administration of steroid medication with in last 3 months
- • Patients with implanted devices like pacemaker
About Northwell Health
Northwell Health is a leading integrated health system based in New York, dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to improving patient outcomes and enhancing medical knowledge, Northwell Health conducts a diverse range of clinical studies across various therapeutic areas. The organization harnesses its extensive network of hospitals, outpatient facilities, and research institutes to facilitate cutting-edge research, ensuring access to advanced treatments for patients while fostering collaboration among healthcare professionals, researchers, and industry partners. By prioritizing patient-centric approaches and leveraging state-of-the-art technology, Northwell Health aims to drive significant advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Leon Popovitz, MD
Principal Investigator
Northwell Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials